Laparoscopic and open partial nephrectomy: complication comparison using the Clavien system.
JSLS., 16(1):38-44 (2012)
Biomolecular predictors of urothelial cancer behavior and treatment outcomes.
Curr Urol Rep., Apr;13(2):122-35 (2012)
Toll-like receptor 7 agonist therapy with imidazoquinoline enhances cancer cell death and increases lymphocytic infiltration and proinflammatory cytokine production in established tumors of a renal cell carcinoma mouse model.
J Oncol., 2012:103298 (2012)
Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk.
Proc. Natl. Acad. Sci. U.S.A., Apr;109(17):6686-91 (2012)
Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current TNM classification.
Eur. Urol., Aug;62(2):224-31 (2012)
Multiphoton microscopy in the evaluation of human bladder biopsies.
Arch. Pathol. Lab. Med., May;136(5):517-26 (2012)
Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Eur. Urol., Apr;61(4):818-25 (2012)
Prognostic value of extranodal extension and other lymph node parameters in patients with upper tract urothelial carcinoma.
J. Urol., Mar;187(3):845-51 (2012)
Prognostic value of insulin-like growth factor II mRNA binding protein 3 in patients treated with radical prostatectomy.
BJU Int., Jul;110(1):63-8 (2012)
Emerging biomarkers for prostate cancer diagnosis, staging, and prognosis.
Arch. Esp. Urol., Oct;64(8):681-94 (2011)
Novel therapeutics for the management of castration-resistant prostate cancer (CRPC).
BJU Int., Apr;109(7):968-85 (2012)
Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessment.
Eur. Urol., Feb;61(2):237-42 (2012)
The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy.
Eur. Urol., Feb;61(2):245-53 (2012)
Decision curve analysis assessing the clinical benefit of NMP22 in the detection of bladder cancer: secondary analysis of a prospective trial.
BJU Int., Mar;109(5):685-90 (2012)
Cost-analysis comparison of robot-assisted laparoscopic radical cystectomy (RC) vs open RC.
BJU Int., Sep;108(6 Pt 2):976-83 (2011)
Preoperative radiographic parameters predict long-term renal impairment following partial nephrectomy.
World J Urol., May (2011)
The economics of robotic cystectomy: cost comparison of open versus robotic cystectomy.
BJU Int., Dec;108(11):1886-92 (2011)
Role of androgen receptor and associated lysine-demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer.
Mol. Carcinog., Dec;50(12):931-44 (2011)
Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomy.
World J Urol., Aug;29(4):473-80 (2011)
Does preoperative symptom classification impact prognosis in patients with clinically localized upper-tract urothelial carcinoma managed by radical nephroureterectomy?
Urol. Oncol., 29(6):716-23 (2011)
The impact of multiple malignancies on patients with bladder carcinoma: a population-based study using the SEER database.
Adv Urol., 406965 (2009)
Robot-assisted laparoscopic radical prostatectomy in the renal allograft transplant recipient.
J. Endourol., Nov;22(11):2475-9 (2008)
Does the presence of hydronephrosis on preoperative axial CT imaging predict worse outcomes for patients undergoing nephroureterectomy for upper-tract urothelial carcinoma?
Urol. Oncol., 29(1):27-32 (2011)
Antitumor effects of an imidazoquinoline in renal cell carcinoma.
Urology., May;73(5):1156-62 (2009)
Generation of functional multipotent adult stem cells from GPR125+ germline progenitors.
Nature., Sep;449(7160):346-50 (2007)
Tumour growth inhibition by an imidazoquinoline is associated with c-Myc down-regulation in urothelial cell carcinoma.
BJU Int., Apr;101(7):894-901 (2008)
Robotic radical prostatectomy: operative technique, outcomes, and learning curve.
JSLS., 11(1):1-7 (2007)
Management of patients with upper urinary tract transitional cell carcinoma.
Nat Clin Pract Urol., Aug;4(8):432-43 (2007)
Antitumor effects of imidazoquinolines in urothelial cell carcinoma of the bladder.
J. Urol., Jun;177(6):2347-51 (2007)
Diagnosis of renal tumors on needle biopsy specimens by histological and molecular analysis.
J. Urol., Nov;176(5):1957-62 (2006)
Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
Urology., Feb;69(2):251-4 (2007)
Hand-assisted laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma.
JSLS., 10(4):432-8 (2006)
Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder.
Clin. Cancer Res., Dec;11(24 Pt 1):8570-6 (2005)
A population-based study of renal cell carcinoma and prostate cancer in the same patients.
BJU Int., Jan;97(1):33-6 (2006)
Five-alpha-reductase expression in benign and malignant urothelium: correlation with disease characteristics and outcome.
Urology., Nov;66(5):1134-9 (2005)
Bladder cancer after managing upper urinary tract transitional cell carcinoma: predictive factors and pathology.
BJU Int., Nov;96(7):1031-5 (2005)
Abnormal selective cytology results predict recurrence of upper-tract transitional-cell carcinoma treated with ureteroscopic laser ablation.
J. Endourol., Nov;18(9):912-6 (2004)
Reduced lecithin: retinol acyltransferase expression correlates with increased pathologic tumor stage in bladder cancer.
Clin. Cancer Res., May;10(10):3429-37 (2004)
Retinoid receptor mRNA expression profiles in human bladder cancer specimens.
Int. J. Oncol., Apr;26(4):1041-8 (2005)
Prostate-specific antigen screening in a high-risk population: lessons from the community and how they relate to large-scale population-based studies.
Urology., May;65(5):931-6 (2005)
Impact of delay to nephroureterectomy for patients undergoing ureteroscopic biopsy and laser tumor ablation of upper tract transitional cell carcinoma.
Urology., Aug;66(2):283-7 (2005)
Multifocal renal cortical tumors: frequency, associated clinicopathological features and impact on survival.
J. Urol., Feb;171(2 Pt 1):615-20 (2004)
Treatment of adrenocortical carcinoma: contemporary outcomes.
Curr Urol Rep., Feb;5(1):65-72 (2004)
Practice patterns among urologic surgeons treating localized renal cell carcinoma in the laparoscopic age: technology versus oncology.
Urology., Dec;62(6):1007-11 (2003)
The nonsteroidal effects of diethylstilbestrol: the rationale for androgen deprivation therapy without estrogen deprivation in the treatment of prostate cancer.
J. Urol., Nov;170(5):1703-8 (2003)
Prostate biopsy techniques and indications: when, where, and how?
Semin. Urol. Oncol., Feb;20(1):18-31 (2002)
Laser tissue welding: a urological surgeon's perspective.
Haemophilia., Jul;4(4):456-62 (1998)
Predictors of cancer-specific mortality after disease recurrence following radical cystectomy.
BJU Int., Sep (2012)
Pathologic Nodal Staging Score for Bladder Cancer: A Decision Tool for Adjuvant Therapy After Radical Cystectomy.
Impact of Distal Ureter Management on Oncologic Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.
Impact of Smoking on Oncologic Outcomes of Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy.
Accurate preoperative prediction of non-organ-confined bladder urothelial carcinoma at cystectomy.
Risk of Cancer-specific Mortality following Recurrence After Radical Nephroureterectomy.
Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy.
Does increasing the nodal yield improve outcomes in patients without nodal metastasis at radical cystectomy?
Extranodal Extension Is a Powerful Prognostic Factor in Bladder Cancer Patients with Lymph Node Metastasis.
Eur. Urol., Jul (2012)
Collaborative Research Networks as a Platform for Virtual Multidisciplinary, International Approach to Managing Difficult Clinical Cases: An Example from the Upper Tract Urothelial Carcinoma Collaboration.
Eur. Urol., Aug (2012)
Impact of Smoking and Smoking Cessation on Oncologic Outcomes in Primary Non-muscle-invasive Bladder Cancer.
Eur. Urol., Aug (2012)
Stage-Specific Impact of Tumor Location on Oncologic Outcomes in Patients With Upper and Lower Tract Urothelial Carcinoma Following Radical Surgery.
Eur. Urol., Oct;62(4):677-684 (2012)
Role of magnetic resonance imaging in bladder cancer: current status and emerging techniques.
International validation of the prognostic value of subclassification for AJCC stage pT3 upper tract urothelial carcinoma of the renal pelvis.
BJU Int., Sep;110(5):674-681 (2012)
Risk stratification of organ confined bladder cancer after radical cystectomy using cell cycle related biomarkers.
J. Urol., Feb;187(2):457-62 (2012)
Update on intravesical agents for non-muscle-invasive bladder cancer.
Immunotherapy., May;2(3):381-92 (2010)
Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy.
Eur. Urol., Jun;57(6):1072-9 (2010)
Critical analysis of complications after robotic-assisted radical cystectomy with identification of preoperative and operative risk factors.
BJU Int., Feb;105(4):520-7 (2010)
Early oncological outcomes for bladder urothelial carcinoma patients treated with robotic-assisted radical cystectomy.
BJU Int., Feb;107(4):628-35 (2011)
Tissue-based molecular markers for bladder cancer.
Minerva Urol Nefrol., Sep;62(3):241-58 (2010)
Human bladder cancer diagnosis using Multiphoton microscopy.
Proc Soc Photo Opt Instrum Eng., 7161 (2009)
A comparison of postoperative complications in open versus robotic cystectomy.
Eur. Urol., Feb;57(2):274-81 (2010)
Robotic vs open radical cystectomy: prospective comparison of perioperative outcomes and pathological measures of early oncological efficacy.
BJU Int., Jan;101(1):89-93 (2008)
Increasing body mass index negatively impacts outcomes following robotic radical prostatectomy.
JSLS., 11(4):438-42 (2007)
Radical prostatectomy in men aged >or=70 years: effect of age on upgrading, upstaging, and the accuracy of a preoperative nomogram.
BJU Int., Mar;101(5):541-6 (2008)
Renal cell carcinoma sub-typing by histopathology and fluorescence in situ hybridization on a needle-biopsy specimen.
BJU Int., Feb;99(2):290-5 (2007)
Decreased expression of the human stem cell marker, Rex-1 (zfp-42), in renal cell carcinoma.
Carcinogenesis., Mar;27(3):499-507 (2006)
Laser Tissue Welding - Poised for the New Millenium.
Surg Technol Int., Oct;IX:33-41 (2000)
Laser tissue welding - poised for the new millenium.
Surg Technol Int., 9:33-41 (2000)
Tissue-based molecular markers for renal cell carcinoma.
Minerva Urol Nefrol., Dec;63(4):293-308 (2011)
Collecting system invasion and Fuhrman grade but not tumor size facilitate prognostic stratification of patients with pT2 renal cell carcinoma.
J. Urol., Dec;186(6):2175-81 (2011)
BCL-2 and p53 expression in clinically localized prostate cancer predicts response to external beam radiotherapy.
J. Urol., Jul;162(1):12-6; discussion 16-7 (1999)
Laser tissue welding.
Urol. Clin. North Am., Feb;25(1):123-35 (1998)
Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes.
J. Urol., May;181(5):2305-11 (2009)
Laser Ablation of Upper Tract Transitional Cell Carcinoma with the Intent on Kidney Preservation: Delay in time to Nephroureterectomy is Not Predictive of Poor Outcome
Journal of Endourology
Receptor Expression is Inversely Correlated with Pathologic Tumor Stage in Transitional Cell Carcinoma of the Bladder
Expression Correlates with Increased Pathologic Tumor Stage in Bladder Cancer
Treatment of Adrenocortical Carcionoma: Contemporary Outcomes
Current Urology Reports
Multifocal renal cortical tumors: frequency, associated clinicopathological features and impact on survival
The Journal of Urology